Augmedix, Inc. (NASDAQ:AUGX) Q1 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, greetings and welcome to the Augmedix, Inc. First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Augmedix Inc. (AUGX)
This company is not actively trading or the ticker does belong to another company in our database now.
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Redmile Group Jeremy Green | 0 | $0 | 0% | |
| 2. | Millennium Management Israel Englander | 0 | $0 | 0% | |
| 3. | Beryl Capital Management David Alexander Witkin | 0 | $0 | 0% | |
| 4. | Vazirani Asset Management Raj Vazirani | 0 | $0 | 0% | |
| 5. | Engineers Gate Manager Greg Eisner | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.85 | 10,000 | $48,500.00 | 128,000 | 2023-11-22 | Filing | |
| $4.00 | 750,000 | $3,000,000.00 | 9,446,146 | 2023-11-20 | Filing | |
| $4.00 | 750,000 | $3,000,000.00 | 16,404,017 | 2023-11-20 | Filing | |
| $4.51 | 26,530 | $119,649.17 | 47,331 | 2023-06-14 | Filing | |
| $4.00 | 1,625,000 | $6,500,000.00 | 6,218,238 | 2021-10-28 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.19 | 1,767 | $2,102.73 | 2,921 | 2024-05-15 | Filing | |
| $1.19 | 1,387 | $1,650.53 | 5,363 | 2024-05-15 | Filing | |
| $1.19 | 2,354 | $2,801.26 | 131,896 | 2024-05-15 | Filing | |
| $1.19 | 1,767 | $2,102.73 | 2,921 | 2024-05-15 | Filing | |
| $1.19 | 3,528 | $4,198.32 | 58,898 | 2024-05-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Should You Invest in Augmedix (AUGX)?
Next Century Growth Investors, LLC, an investment Management Company, released its “Micro-Cap Strategy” fourth-quarter investor letter. A copy of the letter can be downloaded here.
Augmedix, Inc. (NASDAQ:AUGX) Q4 2023 Earnings Call Transcript
Augmedix, Inc. beats earnings expectations. Reported EPS is $-0.09, expectations were $-0.1.
10 Stocks George Soros and Insiders Are Crazy About
In this article, we will take a detailed look at the 10 Stocks George Soros and Insiders Are Crazy About. For a quick overview of such stocks, read our article 5 Stocks George Soros and Insiders Are...
5 Best-Performing Growth Stocks in 2023
DraftKings Inc. (NASDAQ:DKNG) shares jumped earlier this month on the back of a strong Q3 earnings report and an upbeat guidance. DraftKings Inc.
Augmedix, Inc. (NASDAQ:AUGX) Q3 2023 Earnings Call Transcript
Operator: Greetings and welcome to Augmedix, Inc. 2023 Third Quarter Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
Augmedix, Inc. (NASDAQ:AUGX) Q2 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, greetings, and welcome to the Augmedix Inc. Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Augmedix, Inc. (NASDAQ:AUGX) Q1 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Augmedix Inc. First Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Augmedix, Inc. (NASDAQ:AUGX) Q4 2022 Earnings Call Transcript
Operator: Greetings, welcome to Augmedix Incorporated 2022 Fourth Quarter Earnings Conference Call. At this time, all participants will be in listen-only mode.
Augmedix, Inc. (NASDAQ:AUGX) Q3 2022 Earnings Call Transcript
Operator: Greetings and welcome to Augmedix, Inc. Third Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode. As a reminder, this conference is being recorded.
Hedge Fund Resource Center Billionaire Hedge Funds
